A chance encounter at university led Dr. Eyal Orion to the Zisapel brothers’ RAD Biomed incubator, setting him on a path to found five medical device companies, including one sold for $100 million. This month, he achieved a second exit with the $497 million sale of Vectorious, developer of a heart failure–detecting sensor.
Acquired-by
Global Pharma Company Exercises Rights for Exclusive Use of Everads Drug Delivery Technology in Specific Retinal Targets
Partners
Belkin Laser announces $12.2 million raised in series B funding
Investment
VasQ™ External Support Awarded Breakthrough Device Designation by the FDA
Customers
Zsquare Named A Silver Winner of the 2020 Edison Awards
CustomersPartners
Vectorious' V-LAP arrives in Israel: Live interview with Dr. Leor Perl
Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies
Partners
Enrollment of the VasQ™ External Support US Pivotal Study Now Complete
Customers
Perflow Medical Receives CE Mark Approval of Novel Cascade™ Agile
CustomersPartners
VGS Completes Enrollment of VEST U.S. Pivotal Trial for the Evaluation of Its Venous External Support Technology for Coronary Bypass Surgery
Customers